Great Work Continues at SwanBio!

bradleygillespieOctober 19, 2021October 19, 2021Uncategorizedadrenomyeloneuropathy, AMN, gene therapy, X-ALD

I was thrilled to read today about the mouse data that they announced today: human ABCD1 shows dose-responsive expression and activity

To my untrained eye, this is fabulous news, and so much better than the plethora of ways that we have seen to lower VLCFA. To actually move on our mutated gene sure looks great to me!

Keep at it SwanBio!

Published by bradleygillespie

I am just a guy with a disease called adrenomyeloneuropathy. I want other guys with the disease to see the good parts of disability. Not the gloom. Not the doom. Make sense? View more posts

One thought on “Great Work Continues at SwanBio!”

bradleygillespie says:

October 19, 2021 at 7:05 pm

Reblogged this on Survivors Blog Here Mental Health Collaborative and commented:

This is fabulous news for us AMN patients. Just a mouse, but you must start somewhere.

LikeLike

Reply

Leave a reply to bradleygillespie Cancel reply